Found: 5
Select item for more details and to access through your institution.
Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 10, p. 1, doi. 10.1007/s00520-024-08868-7
- By:
- Publication type:
- Article
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 3, p. 507, doi. 10.1093/ndt/gfaa372
- By:
- Publication type:
- Article
Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study*.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 3, p. 401, doi. 10.1111/bjd.21241
- By:
- Publication type:
- Article
High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article